Polaryx Therapeutics (PLYX) Operating Income (2025 - 2026)
Polaryx Therapeutics (PLYX) posted quarterly Operating Income of -$2.0 million for Q1 2026, up 61.24% year-over-year from -$1.2 million in Q1 2025, and up 61.24% quarter-over-quarter from -$5.1 million in Q1 2025.
Polaryx Therapeutics (PLYX) Operating Income (2025 - 2026) Analysis & Trends
Polaryx Therapeutics (PLYX) has reported Operating Income for 2 consecutive years, with -$2.0 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 133.12 Mn |
| 10 | Polaryx Therapeutics | 101.38 Mn | 89.84 Mn | - | -1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.38 Mn |
| Mar 31, 2026 | -1.96 Mn |
| Mar 31, 2025 | -5.05 Mn |